Sandrine Gaillard
Biopharma Executive Advisor

Advising biotech companies and investors on European launch strategy, commercial readiness, and portfolio decisions

European Launch Strategy

Supporting biotech companies preparing for their first launch in Europe.

  • Market prioritization and sequencing

  • Go-to-market model (independent vs. partner vs. hybrid)

  • Organizational design and resource allocation

Advisory & Interim Leadership

Engagements at board, CEO, and executive level in high-stakes situations.

  • Board and CEO advisory

  • Interim leadership (e.g. SVP Europe)

  • Support in time-sensitive or complex environments

Commercial & Portfolio Strategy

Commercial input to support portfolio prioritization and investment decisions.

  • Asset prioritization and sequencing

  • Payer and access strategy

  • Commercial perspective on development decisions

Experience & Track Record

20+ years of global biopharma leadership across commercial strategy, P&L, and new product planning.

  • €350M+ regional P&L across 15+ countries

  • Built and transformed organizations across Europe, U.S., and APAC

  • Leadership roles across rare disease, oncology, and specialty care

© 2026 Sandrine Gaillard. All rights reserved.